These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Predicting Incremental and Future Visual Change in Neovascular Age-Related Macular Degeneration Using Deep Learning. Fu DJ; Faes L; Wagner SK; Moraes G; Chopra R; Patel PJ; Balaskas K; Keenan TDL; Bachmann LM; Keane PA Ophthalmol Retina; 2021 Nov; 5(11):1074-1084. PubMed ID: 33516917 [TBL] [Abstract][Full Text] [Related]
44. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis. Ba J; Peng RS; Xu D; Li YH; Shi H; Wang Q; Yu J Drug Des Devel Ther; 2015; 9():5397-405. PubMed ID: 26451092 [TBL] [Abstract][Full Text] [Related]
49. Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study). Bhisitkul RB; Desai SJ; Boyer DS; Sadda SR; Zhang K Ophthalmology; 2016 Jun; 123(6):1269-77. PubMed ID: 26996339 [TBL] [Abstract][Full Text] [Related]
50. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Cho HJ; Park SM; Kim J; Nah SK; Lee J; Lee DW; Kim JW Acta Ophthalmol; 2021 Jun; 99(4):e540-e546. PubMed ID: 32996674 [TBL] [Abstract][Full Text] [Related]
51. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population. Medina FMC; Motta AALD; Takahashi WY; Carricondo PC; Motta MMDS; Melo MB; Vasconcellos JPC Ophthalmic Res; 2019; 61(3):168-173. PubMed ID: 28641277 [TBL] [Abstract][Full Text] [Related]
52. The Impact of Epiretinal Membrane in Neovascular Age-Related Macular Degeneration Treatment: A Spectral-Domain Optical Coherence Tomography Study. Chatziralli I; Stavrakas P; Theodossiadis G; Ananikas K; Dimitriou E; Theodossiadis P Semin Ophthalmol; 2018; 33(5):651-656. PubMed ID: 29115893 [TBL] [Abstract][Full Text] [Related]
53. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration. Cobos E; Recalde S; Anter J; Hernandez-Sanchez M; Barreales C; Olavarrieta L; Valverde A; Suarez-Figueroa M; Cruz F; Abraldes M; Pérez-Pérez J; Fernández-Robredo P; Arias L; García-Layana A Acta Ophthalmol; 2018 Mar; 96(2):e201-e212. PubMed ID: 28926193 [TBL] [Abstract][Full Text] [Related]
54. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis. Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283 [No Abstract] [Full Text] [Related]
55. PHARMACOKINETIC STUDY OF INTRAVITREAL AFLIBERCEPT IN HUMANS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Do DV; Rhoades W; Nguyen QD Retina; 2020 Apr; 40(4):643-647. PubMed ID: 31145389 [TBL] [Abstract][Full Text] [Related]
56. Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial. Zehetner C; Kralinger MT; Modi YS; Waltl I; Ulmer H; Kirchmair R; Bechrakis NE; Kieselbach GF Acta Ophthalmol; 2015 Mar; 93(2):e154-9. PubMed ID: 25488124 [TBL] [Abstract][Full Text] [Related]
57. Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial). Wykoff CC; Brown DM; Maldonado ME; Croft DE Br J Ophthalmol; 2014 Jul; 98(7):951-5. PubMed ID: 24518078 [TBL] [Abstract][Full Text] [Related]
58. Pilot study to evaluate the role of high-dose ranibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with persistent/recurrent macular fluid <30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study). Fung AT; Kumar N; Vance SK; Slakter JS; Klancnik JM; Spaide RS; Freund KB Eye (Lond); 2012 Sep; 26(9):1181-7. PubMed ID: 22878451 [TBL] [Abstract][Full Text] [Related]
59. Predictive findings of visual outcome in spectral domain optical coherence tomography after ranibizumab treatment in age-related macular degeneration. Kwon YH; Lee DK; Kim HE; Kwon OW Korean J Ophthalmol; 2014 Oct; 28(5):386-92. PubMed ID: 25276080 [TBL] [Abstract][Full Text] [Related]
60. Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration. ElShelmani H; Brennan I; Kelly DJ; Keegan D Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]